Cholesterol production inhibitor (statin) increased bone healing in surgically created femoral defect in an animal model

Biomedical Sciences Instrumentation

Volumn 43, Issue , 2007, Pages 95-103

  Adah, Felix ^a   Benghuzzi, Hamed ^a   Tucci, Michelle ^a   Russell, George ^a   England, Barry ^b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Biochemical markers; Drug delivery system; Fracture; Healing; Osteogenic agent; Simvastatin; Statins; Tricalcium phosphate lysine

Indexed keywords

BIOLOGICAL ORGANS; BIOMARKERS; CHOLESTEROL; DRUG DELIVERY; AMINO ACIDS; BIOCHEMISTRY; BONE; DEFECTS; FRACTURE; INSTRUMENTS; LANDFORMS; MUSCLE;

BIOCHEMICAL MARKERS; OSTEOGENIC AGENTS; SIMVASTATIN; STATINS; TRICALCIUM PHOSPHATE LYSINE;

BIOMECHANICS; ANIMALS;

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMUR MALFORMATION; FRACTURE HEALING; GENITAL SYSTEM; HISTOPATHOLOGY; LABORATORY TEST; MALE; MORPHOMETRICS; NONHUMAN; RAT; SKELETAL MUSCLE;

ANIMALS; ANTICHOLESTEREMIC AGENTS; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; FEMORAL FRACTURES; FEMUR; FRACTURE HEALING; MALE; OSTEOGENESIS; RATS; RATS, SPRAGUE-DAWLEY; SIMVASTATIN; TREATMENT OUTCOME; VANCOMYCIN;

BIOCHEMICAL MARKERS; DRUG DELIVERY SYSTEM; HEALING; OSTEOGENIC; SIMVASTATIN; STATINS; TRI-CALCIUM PHOSPHATES;

EID: 34247600945     PISSN: 00678856     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (50)

1. Hannouche, D, Petite, H, Sedel, L. Current trends in the enhancement of fracture healing. J Bone Joint Surg. 2001; 83-B:157-164.
2. Bouletreau, PJ, Warren, SM, and Longaker, MT. The molecular biology of distraction osteogenesis. J Craniomaxillofac Surg. 2002;30 (1):1-11.
3. Mundy, G, Garrett, R, Harris, S, Chan, J, Chen, G, Rossini, G, Boyce, B, Zhao, M, and Gutierrez, G. Stimulation of bone formation in vitro and in rodents by statins. Science. 1999;286:946-1949.
4. Cuevas, P, Carceller, F, Ortega, S, Zazo, M, Nieto, I, and Gimenez-Gallego, G. ] Hypotensive activity of fibroblast growth factor. Science. 1991; 254:1208-1210.
5. Harris, SE, Bonewald, LF, Harris, MA, Sabatini, M, Dallas, S, Feng, JQ, Ghosh-Choudhury, N, Wozney, J, and Mundy, GR. Effects of transforming growth factor B on bone nodule formation expression of bone morphogenetic protein-2, osteocalcin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. Journal of Bone and Mineral Research. 1994;9(6): 855-862.
6. Peter, CP, Cook, WO, Numamaker, DM, Provost, MT, Seedor, JG, and Rodan, GA. Effects of alendronate on fracture healing and bone remodeling in dog. Journal of Orthopaedic Research. 1996;14(1):74-79.
7. Li, J, Mori, S, Kayi, Y, Mashiba, T, Kawanishi, J, and Norimatsu, H. Effect of bisphosphonate (incadronate) on fracture healing of long bones in rats. Journal of Bone and Mineral Research. 1999;14(6): 969-979.
8. Ohnaka, K, Shimoda, S, Nawata, H, Shimokawa, H, Kaibuchi K, Iwamoto, Y, and Takayanagi, R. Pravastatin enchanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts. Biochem Biophys Res Commun. 2001;287(2):337-342.
9. Garrett, R, and Mundy, GR. The role of statins as potential targets for bone formation. Arthritis Res. 2002;4 (4):237-240.
10. Staal, A, Frith, JC, French, MH, Swartz, J, Gungor, T, Harrity, TW, Tamasi, J, Rogers, and Feyen, JH. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity. J Bone Miner Res. 2003;18(1):88-96.
11. Edwards, CJ, and Spector, TD, (2002). Statins and modulators of bone formation. Arthritis Res. 2002;4(3):151-153.
12. Sica, DA, and Gehr, TW. Rhabdomyolysis and statin therapy: Relevance to the elderly. Am J Geriatr Cardiol. 2002;1(1):48-55.
13. Corsini, A Bellosta, S, Baetta, R, Fumagalli, R, Paoletti, R, and Bernini, F. New insights into the pharmacodynamic and pharmacokinetic properties of statins. Pharmacol Ther. 2000; 84 (3):413-428.
14. Bauer, DC, Mundy, GR, Jamal, SA, Black, DM, Cauley, JA, Insrud, KE, van der Klift, M, and Pols, HA. Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials. Arch Inter Med. 2004;164(2):146-152.
15. Adah, F, Benghuzzi, H, Tucci, M, Russell, G, Tsao, A, Olivier, J, England, B. Evaluation pf the male reproductive organs after treatment with continuous sustained delivery of statin for fracture healing. Biomedical Sciences Instrumentation, 2005;41:54-61.
16. Radin, S, Campbell, JT, Ducheyne, P, and Cuckler, JM. Calcium phosphate ceramic coatings as carriers of vancomycin. Biomaterials. 1997;18(11):777-782.
17. Taggart, T, Kerry, RM, Normal, P, and Stockey, I. The use of vancomycin-impregnated cement beads in the management of infection of prosthetic joints. J of Bone & Joint Surg. 2002;84(1): 70-72.
18. von Knoch, F, Heckelei, A, Wedemeyer, C, Saxler, G, Hilken, G, Henschke, F, Loer, F, and Knoch, M. The effect of simvastatin on polyethylene-induced osteolysis. Biomaterials, 2005;26(17):3549-3555.
19. Oxlund, H, and Andreassen, TT. Simvastatin treatment partially prevents overiectomy-induced bone loss while increasing cortical bone formation. Bone, 2004;34(4):609-618.
20. Meier, CR, Schlienger, RG, Kraenzlin, ME, Schlegel, B, and Jick, H. HMG-CoA reductase inhibitors and the risk of fractures. JAMA. 2000;283(24): 3205-3210.
21. Wang, PS, Solomon, DH, Mogun, H, and Avorn, J. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients.(comment). JAMA. 2000;283(24): 3211-3216.
22. Chan, KA, Andrad, SE, Boles, M, Buist, DSM, Chase, GA, Donahue, JG, Goddman, MJ, Gurwitz, JH, LaCroix, AZ, and Platt, R. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women. The Lancet. 2002;355(9222): 2185-2188.
23. Edwards, CJ, Hart, DJ, and Spector, TD. Oral stains and increased bone-mineral density in post-menopausal women. Lancet. 2000;355 (9222): 2218-2219.
24. Reid, IR, Hague, W, Emberson, J, Baker, J, Tonkin, A, Hunt, D, MacMahon, S, and Sharpe, N. Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long term intervention with pravastatin in ischaemic disease. Lancet. 2001;357(9255):509-512.
25. Van Staal, TP, Wegman, S, de Varies, F, Leufkens, B, and Cooper, C. Use of statins and risk of fractures. JAMA. 2001;285:1850-1855.
26. Benghuzzi, H. The effect of sustained delivery of androstendion on the functional activities of adult male rats. Biomedical Sciences Instrumentation. 1998;34:7-12.
27. Benghuzzi, HA, and England, BG. The effect of sustained delivery of danazol and antioxidants on lipoprotein profiles of adult female mice. Biomedical Sciences Instrumentation. 1995;31:171-176.
28. Cavett, W, Tucci, M, Cason, Z, Lemos, L, and England, B. Cellular responses to various levels of sustained delivery of testosterone in the ventral prostate. Biomedical Sciences Instrumentation. 1997;33: 155-160.
29. Varnado, M, Tucci, M, Cason, Z, Mohamed, A, and Benghuzzi, H. Germinal cell alterations associated with sustained delivery of testosterone enanthate in adult male rats. Biomedical Sciences Intrumentation. 1997;33:161-165.
30. Nagy, EA, and Bajpai, PK. Development of a ceramic matrix system for continuous delivery of azidothymidine. Biomedical Sciences Instrumentation. 1994;30:181-186.
31. England, BG, Benghuzzi, HA, Possley, RM, and Bajpai, PK. The effect of various testosterone concentrations released from ceramic delivery systems on the circulating hormone levels of adult castrated rams. Biomedical Sciences Instrumentation. 1991;27:89-195.
32. Benghuzzi, HA, England, BG, and Bajpai, PK. Tricalcium phosphate amino acid capsules as a drug delivery system for steroid hormones. Biomedical Sciences Instrumentation. 1991;27:197-203.
33. Benghuzzi, HA, Barbaro, RM, and Bajpai, PK. In vitro release of azidothymidine (AZT) by ceramic drug delivery. Biomedical Sciences Instrumentation. 1990;26:151-156.
34. Benghuzzi, HA, Possley, R, and England, BG. Pulsatile delivery of progesterone and estradiol to mimic the ovulatory surge in adult ewes by means of TCPL implants. Biomedical Sciences Instrumentation. 1994;30:187-196.
35. Conflitti, J, Graves, M, Russell, G, Tucci, M, and Benghuzzi, H. Plating of rat femoral shaft osteotomies: Report of a technique and preliminary results. Biomedical Sciences Instrumentation. 2003;39:278-283.
36. Tramontana J, Benghuzzi H, Tucci M, Tsao A, and Hughes J. Morphometric analysis of cortical bone upon the exposure to sustained delivery of anabolic promoting agents using adult male rats as a model. Biomedical Science Intrumentaion. 2001;37:293-298.
37. Adah, F, Benghuzzi, H, Tucci, M, Russell, G, and England, B. Effects of sustained release of statin by means of tricalcium phosphate lysine delivery system in defect and segmental femoral injuries on certain biochemical markers in vivovaluation pf the male reproductive organs after treatment with continuous sustained delivery of statin for fracture healing. Biomedical Sciences Instrumentation, 2006;42:126-135.
38. Higdon, K, Scott, A, Tucci, M, Benghuzzi, H, Tsao, A, Puckett, A, Cason, Z, and Hughes, J. The Use of estrogen, DHEA, and diosgenin in a sustained delivery setting as a novel treatment approach for osteoporosis in the ovariectomized adult rat model. Biomedical Sciences Instrumentation. 2001;(37):281-286.
39. Scott, A, Higdon, K, Tucci, M, Benghuzzi, H, Puckett, A, Tsao, A, Cason, Z, and Hughes, J. The prevention of osteoporotic progression by means of steroid loaded TCPL Drug Delivery systems. Biomedical Sciences Instrumentation. 2003; (37): 13-18.
40. Thylin, MR, McConnell, JC, Schmid, MJ, Reckling, RR, Ojha, J, Bhattacharyya, I, Marx, DB, and Reinhardt, RA. Effects of simvastatin gels on murine calvarial bone. Journal of Periodontology. 2002;73(10):1141-1148.
41. Skoglund, B, Forslund, C, and Aspenberg, P. Simvastatin improves fracture healing in mice. J Bone Miner Res. 2002; (11): 2004-2008.
42. Sirola, J, Honkanen, R, Kroger, H, Jurbelin, JS, Maenpaa, P, and Saarikoski, S. Relation of statin use and bone loss: A prospective population-based cohort study in early post-menmopausal women. Osteoporosis International. 2002; 13(7): 537-541.
43. Chan MH, Mak, TW, Chiu, RW, Chow, CC, Chan, IH, Lam, CW. Simvastatin increases serum osteocalcin concentration in patients treated for hypercholesterolaemia. Journal of Clinical Endocrinology and Metabolism. 2001; 86 (9):4556-4559.
44. Stein, EA, Farnier, M, Waldstreicher, J, and Mercuri, M. Effects of statins on biomarkers of bone metabolism: A randomised trial. Nutrition Metabolism & Cardiovascular Diseases. 2001;11(2):84-87.
45. Oxlund, H, Dalstra, M, and Andressen, TT. Statin given perorally to adult rats increases cancellous bone mass and compressive strength. Calcified Tissue International. 2001;69(5):299-304.
46. LaCroix, AZ, Cauley, JA, Petringer, M, Hisia, J, Bauer DC, McGowan, J, Chen, Z, Lewis, CE, McNeeley, SG, Passaro, MD, and Jackson, RD. Statin use, clinical fracture, and bone density in post-menopausal women: Results from the Women's Health Initiative Observational Study. Ann Intern Med. 2003;139(2):97-104.
47. Calhoun, JH, and Mader, JT. Treatment of osteomyelitis with a biodegradable antibiotic implant. Clin Orthopedic and Related Research. 1997;(341):206-214.
48. Wachol-Drewek, Z, Pfeiffer, M, and Scholl, E. Comparative investigation of drug delivery of collagen implants saturated in antibiotic solutions and a sponge containing gentimicin. Biomaterials. 1996;17(17):1773-1778.
49. Street, J, Bao, M, deGuzman, L, Bunting, S, Peale, FV Jr, Ferrara, N, Steinmetz, H, Hoeffel, J, Cleland, JL, Daugherty, A, van Bruggen, N, Redmond, HP, Carano, RA, and Filvaroff, EH. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proceedings of the National Academic Sciences of the United States of America. 2002;99(15): 9656-9661.
50. Glowacki, J. Angiogenesis in fracture repair. Clinical Orthopedic and Related Research. 1998;355S:S82-S89.